Tuticorin Alkali Chem And Fertil Share Price
Sector: Chemical Manufacturing
80.00 -0.01 (-0.01%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
80.00
Today’s High
80.82
52 Week Low
72.00
52 Week High
112.00
Key Metrics
- Market Cap (In Cr) 974.81
- Beta -0.09
- Div. Yield (%) 0
- P/B 6.9
- TTM P/E 15.28
- Sector P/E 17.63
- D/E 0.01
- Open Price 80
- Prev Close 80.01
Tuticorin Alkali Chem And Fertil Analysis
Price Analysis
-
1 Week-0.9%
-
3 Months2.68%
-
6 Month-6.57%
-
YTD-18.32%
-
1 Year-10.67%
Risk Meter
- 43% Low risk
- 43% Moderate risk
- 43% Balanced Risk
- 43% High risk
- 43% Extreme risk
Tuticorin Alkali Chem And Fertil Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 309.49
- Selling/ General/ Admin Expenses Total
- 21.38
- Depreciation/ Amortization
- 6.71
- Other Operating Expenses Total
- 47.66
- Total Operating Expense
- 231.24
- Operating Income
- 78.25
- Net Income Before Taxes
- 79.59
- Net Income
- 62.19
- Diluted Normalized EPS
- 3.63
- Period
- 2025
- Total Assets
- 520.88
- Total Liabilities
- 379.68
- Total Equity
- 141.2
- Tangible Book Valueper Share Common Eq
- 11.59
- Period
- 2025
- Cashfrom Operating Activities
- -7.63
- Cashfrom Investing Activities
- -77.92
- Cashfrom Financing Activities
- 86.11
- Net Changein Cash
- 0.57
- Period
- 2024
- Total Revenue
- 320.36
- Selling/ General/ Admin Expenses Total
- 50.57
- Depreciation/ Amortization
- 4.11
- Other Operating Expenses Total
- 6.13
- Total Operating Expense
- 252.12
- Operating Income
- 68.24
- Net Income Before Taxes
- 66.62
- Net Income
- 69.61
- Diluted Normalized EPS
- 5.95
- Period
- 2024
- Total Assets
- 417.42
- Total Liabilities
- 338.25
- Total Equity
- 79.17
- Tangible Book Valueper Share Common Eq
- 6.5
- Period
- 2024
- Cashfrom Operating Activities
- 12.91
- Cashfrom Investing Activities
- -15.35
- Cashfrom Financing Activities
- 2.43
- Net Changein Cash
- -0.01
- Period
- 2023
- Total Revenue
- 510.95
- Selling/ General/ Admin Expenses Total
- 47.02
- Depreciation/ Amortization
- 3.68
- Other Operating Expenses Total
- 7.92
- Total Operating Expense
- 416.84
- Operating Income
- 94.11
- Net Income Before Taxes
- 78.76
- Net Income
- 101.18
- Diluted Normalized EPS
- 8.3
- Period
- 2023
- Total Assets
- 538.24
- Total Liabilities
- 528.57
- Total Equity
- 9.67
- Tangible Book Valueper Share Common Eq
- 0.79
- Period
- 2023
- Cashfrom Operating Activities
- 13.91
- Cashfrom Investing Activities
- -10.15
- Cashfrom Financing Activities
- -4.61
- Net Changein Cash
- -0.85
- Period
- 2022
- Total Revenue
- 174.52
- Selling/ General/ Admin Expenses Total
- 38.62
- Depreciation/ Amortization
- 3.04
- Other Operating Expenses Total
- 10.92
- Total Operating Expense
- 211.17
- Operating Income
- -36.65
- Net Income Before Taxes
- -33.97
- Net Income
- -33.97
- Diluted Normalized EPS
- -2.79
- Period
- 2022
- Total Assets
- 144.16
- Total Liabilities
- 433.93
- Total Equity
- -289.77
- Tangible Book Valueper Share Common Eq
- -23.78
- Period
- 2022
- Cashfrom Operating Activities
- 9.3
- Cashfrom Investing Activities
- -7.69
- Cashfrom Financing Activities
- -1.02
- Net Changein Cash
- 0.6
- Period
- 2021
- Total Revenue
- 65.94
- Selling/ General/ Admin Expenses Total
- 11.5
- Depreciation/ Amortization
- 3.23
- Other Operating Expenses Total
- 26.18
- Total Operating Expense
- 123.96
- Operating Income
- -58.02
- Net Income Before Taxes
- -58
- Net Income
- -58
- Diluted Normalized EPS
- -4.76
- Period
- 2021
- Total Assets
- 107.8
- Total Liabilities
- 363.7
- Total Equity
- -255.89
- Tangible Book Valueper Share Common Eq
- -21
- Period
- 2021
- Cashfrom Operating Activities
- 5.65
- Cashfrom Investing Activities
- -2.74
- Cashfrom Financing Activities
- -3.95
- Net Changein Cash
- -1.04
- Period
- 2020
- Total Revenue
- 156.64
- Selling/ General/ Admin Expenses Total
- 12.65
- Depreciation/ Amortization
- 3.37
- Other Operating Expenses Total
- 39.96
- Total Operating Expense
- 181.48
- Operating Income
- -24.84
- Net Income Before Taxes
- -23.63
- Net Income
- -23.63
- Diluted Normalized EPS
- -1.94
- Period
- 2020
- Total Assets
- 132.74
- Total Liabilities
- 330.66
- Total Equity
- -197.92
- Tangible Book Valueper Share Common Eq
- -16.25
- Period
- 2020
- Cashfrom Operating Activities
- 3.32
- Cashfrom Investing Activities
- -0.18
- Cashfrom Financing Activities
- -1.87
- Net Changein Cash
- 1.27
- Period
- 2019
- Total Revenue
- 174.8
- Selling/ General/ Admin Expenses Total
- 12.55
- Depreciation/ Amortization
- 3.47
- Other Operating Expenses Total
- 43.97
- Total Operating Expense
- 211.34
- Operating Income
- -36.54
- Net Income Before Taxes
- -37.91
- Net Income
- -37.91
- Diluted Normalized EPS
- -4.18
- Period
- 2019
- Total Assets
- 121.56
- Total Liabilities
- 295.93
- Total Equity
- -174.37
- Tangible Book Valueper Share Common Eq
- -14.31
- Period
- 2019
- Cashfrom Operating Activities
- -67.83
- Cashfrom Investing Activities
- -0.69
- Cashfrom Financing Activities
- 68.44
- Net Changein Cash
- -0.08
- Period
- 2025-03-31
- Total Revenue
- 80.9
- Selling/ General/ Admin Expenses Total
- 5.52
- Depreciation/ Amortization
- 2.84
- Other Operating Expenses Total
- 15.63
- Total Operating Expense
- 67.91
- Operating Income
- 12.99
- Net Income Before Taxes
- 13.14
- Net Income
- 7.24
- Diluted Normalized EPS
- 0.59
- Period
- 2025-03-31
- Total Assets
- 520.88
- Total Liabilities
- 379.68
- Total Equity
- 141.2
- Tangible Book Valueper Share Common Eq
- 11.59
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -7.63
- Cashfrom Investing Activities
- -77.92
- Cashfrom Financing Activities
- 86.11
- Net Changein Cash
- 0.57
- Period
- 2024-12-31
- Total Revenue
- 81.86
- Selling/ General/ Admin Expenses Total
- 5.66
- Depreciation/ Amortization
- 1.23
- Other Operating Expenses Total
- 10.49
- Total Operating Expense
- 63.36
- Operating Income
- 18.5
- Net Income Before Taxes
- 17.28
- Net Income
- 4.89
- Diluted Normalized EPS
- 0.4
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 74.42
- Selling/ General/ Admin Expenses Total
- 5.57
- Depreciation/ Amortization
- 1.65
- Other Operating Expenses Total
- 9.56
- Total Operating Expense
- 62.19
- Operating Income
- 12.23
- Net Income Before Taxes
- 13.35
- Net Income
- 13.87
- Diluted Normalized EPS
- 1.14
- Period
- 2024-09-30
- Total Assets
- 488.8
- Total Liabilities
- 359.79
- Total Equity
- 129.01
- Tangible Book Valueper Share Common Eq
- 10.59
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -12.2
- Cashfrom Investing Activities
- -39.53
- Cashfrom Financing Activities
- 56.77
- Net Changein Cash
- 5.05
- Period
- 2024-06-30
- Total Revenue
- 72.32
- Selling/ General/ Admin Expenses Total
- 4.62
- Depreciation/ Amortization
- 0.99
- Other Operating Expenses Total
- 11.98
- Total Operating Expense
- 37.78
- Operating Income
- 34.53
- Net Income Before Taxes
- 35.82
- Net Income
- 36.18
- Diluted Normalized EPS
- 1.75
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 56.03
- Selling/ General/ Admin Expenses Total
- 2.78
- Depreciation/ Amortization
- 1
- Other Operating Expenses Total
- 11.23
- Total Operating Expense
- 46.34
- Operating Income
- 9.68
- Net Income Before Taxes
- 8.97
- Net Income
- 11.97
- Diluted Normalized EPS
- 1.2
- Period
- 2024-03-31
- Total Assets
- 417.42
- Total Liabilities
- 338.25
- Total Equity
- 79.17
- Tangible Book Valueper Share Common Eq
- 6.5
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 12.91
- Cashfrom Investing Activities
- -15.35
- Cashfrom Financing Activities
- 2.43
- Net Changein Cash
- -0.01
- Period
- 2023-12-31
- Total Revenue
- 76.15
- Selling/ General/ Admin Expenses Total
- 3.46
- Depreciation/ Amortization
- 1.42
- Other Operating Expenses Total
- 8.95
- Total Operating Expense
- 56.61
- Operating Income
- 19.54
- Net Income Before Taxes
- 19.16
- Net Income
- 19.16
- Diluted Normalized EPS
- 1.54
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Tuticorin Alkali Chem And Fertil Technical
Moving Average
SMA
- 5 Day80.3
- 10 Day80.13
- 20 Day77.51
- 50 Day77.27
- 100 Day81.19
- 300 Day86.99
Tuticorin Alkali Chem And Fertil Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Uniphos Enterprises
- 150.1
- -3.15
- -2.06
- 196
- 123.1
- 1048.33
- Veritas India
- 385.75
- 7.55
- 2
- 1329.75
- 353.55
- 1034.19
- Tuticorin Alkali Chem And Fertil
- 80
- -0.01
- -0.01
- 112
- 72
- 974.81
- Bodal Chemicals
- 75.92
- 2.2
- 2.98
- 88
- 49.6
- 956.17
- Transpek Industry
- 1647
- 23.1
- 1.42
- 1896
- 1100.05
- 916.5
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Uniphos Enterprises
- 3755
- 0.38
- 1.2
- 94.86
- Veritas India
- 9.11
- 0.39
- 5.45
- 4.31
- Tuticorin Alkali Chem And Fertil
- 22.02
- 6.9
- -
- 10.21
- Bodal Chemicals
- 34.54
- 0.86
- 4.01
- 2.52
- Transpek Industry
- 19.01
- 1.25
- 9.73
- 8.66
Tuticorin Alkali Chem And Fertil Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 07-May-25
- Audited Results
- 03-Feb-25
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 06-Aug-24
- Quarterly Results
- 15-May-24
- Audited Results
- 09-Feb-24
- Quarterly Results
- 02-Nov-23
- Quarterly Results
- 09-Aug-23
- Quarterly Results
- 24-May-23
- Audited Results
- 30-Jan-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 12-Sept-24
- 12-Aug-24
- AGM
- 25-Sept-23
- 05-Sept-23
- AGM
- 13-Aug-23
- 12-Jul-23
- POM
- 27-Aug-21
- 23-Jul-21
- AGM



